Literature DB >> 1580292

Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia.

P C Singhal1, A Kumar, L Desroches, N Gibbons, J Mattana.   

Abstract

PURPOSE: We undertook this study to determine the prevalence and predictors of rhabdomyolysis in the hypophosphatemic state. PATIENTS AND METHODS: To identify patients with hypophosphatemia, we reviewed medical admissions for the period of January through December 1989. The hypophosphatemic state was considered whenever the serum phosphate was less than or equal to 2.0 mg/dL. Rhabdomyolysis secondary to hypophosphatemia was defined when serum creatine kinase levels were greater than or equal to 224 IU/L; it occurred within 72 hours of the hypophosphatemic episode; and it subsequently normalized. Patients who had any other independent etiology for rhabdomyolysis were excluded. Clinical and biochemical characteristics of patients with rhabdomyolysis (Group I) and patients without rhabdomyolysis (Group II) were compared. Variables that predicted rhabdomyolysis in hypophosphatemia were identified by stepwise logistic regression using a backward elimination procedure.
RESULTS: One hundred twenty-nine patients were found to have hypophosphatemia. Forty-six (Group I) of 129 patients (36%) showed biochemical evidence of rhabdomyolysis. There was no difference in serum phosphate and potassium concentrations between Group I and Group II patients. Patients in Group I showed higher values for serum osmolality (p less than 0.05), serum glutamic oxaloacetic transaminase (p less than 0.001), chloride (p less than 0.01), and blood urea nitrogen (less than 0.05) when compared with Group II patients. When biochemical profiles of patients with rhabdomyolysis were evaluated on the day of their peak creatine kinase level, only 16 patients were hypophosphatemic, and the majority of patients showed a transient increase in serum phosphate levels because of ongoing muscle cell injury. Of 17 potential predictors, six variables emerged including sodium, chloride, glucose, blood urea nitrogen, uric acid, and osmolality. These variables provided high sensitivity (0.88) as well as moderate specificity (0.79) for predicting the occurrence of rhabdomyolysis in hypophosphatemia.
CONCLUSION: We conclude that rhabdomyolysis commonly occurs in the hypophosphatemic state and that at times severe hypophosphatemia as an etiology may be masked because of ongoing rhabdomyolysis. Serum sodium, chloride, glucose, blood urea nitrogen, uric acid, and osmolality have a predictive role for the occurrence of rhabdomyolysis in the hypophosphatemic state that shows a high specificity and a moderate sensitivity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580292     DOI: 10.1016/0002-9343(92)90740-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  Diabetes and rhabdomyolysis. A rare complication of a common disease.

Authors:  G M Lord; J Scott; C D Pusey; A J Rees; M J Walport; K A Davies; C Bulpitt; S R Bloom; F M Muntoni
Journal:  BMJ       Date:  1993-10-30

2.  Single-dose-dexketoprofen-induced acute kidney injury due to massive rhabdomyolysis.

Authors:  Tansu Sav; Aydin Unal; Abdulsamet Erden; Ali Ihsan Gunal
Journal:  Int Urol Nephrol       Date:  2011-05-07       Impact factor: 2.370

Review 3.  From quail to earthquakes and human conflict: a historical perspective of rhabdomyolysis.

Authors:  Mirna Aleckovic-Halilovic; Mirha Pjanic; Enisa Mesic; Joshua Storrar; Alexander Woywodt
Journal:  Clin Kidney J       Date:  2020-05-22

4.  Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury.

Authors:  Helmut Schiffl; Susanne M Lang
Journal:  Int Urol Nephrol       Date:  2012-01-07       Impact factor: 2.370

Review 5.  Treatment of hypophosphatemia in the intensive care unit: a review.

Authors:  Daniël A Geerse; Alexander J Bindels; Michael A Kuiper; Arnout N Roos; Peter E Spronk; Marcus J Schultz
Journal:  Crit Care       Date:  2010-08-03       Impact factor: 9.097

Review 6.  Muscle-Bone Interactions in Pediatric Bone Diseases.

Authors:  Louis-Nicolas Veilleux; Frank Rauch
Journal:  Curr Osteoporos Rep       Date:  2017-10       Impact factor: 5.096

7.  Disturbance of inorganic phosphate metabolism in diabetes mellitus: clinical manifestations of phosphorus-depletion syndrome during recovery from diabetic ketoacidosis.

Authors:  Jørn Ditzel; Hans-Henrik Lervang
Journal:  Diabetes Metab Syndr Obes       Date:  2010-09-20       Impact factor: 3.168

Review 8.  Intravenous iron administration and hypophosphatemia in clinical practice.

Authors:  S Hardy; X Vandemergel
Journal:  Int J Rheumatol       Date:  2015-04-27

9.  Risk factors for acute kidney injury in severe rhabdomyolysis.

Authors:  Eva Rodríguez; María J Soler; Oana Rap; Clara Barrios; María A Orfila; Julio Pascual
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

10.  Short-Term High-Dose Steroid Therapy in a Case of Rhabdomyolysis Refractory to Intravenous Fluids.

Authors:  Fnu Zarlasht; Mashal Salehi; Alamgir Sattar; Mohammad Abu-Hishmeh; Muzammil Khan
Journal:  Am J Case Rep       Date:  2017-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.